Veritable’s Precision BioSciences DTIL Stock Holding History

Veritable’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-882	Closed	-$13.9K	–	229
2023 Q2	$13.9K	Hold	882	–	–	﹤0.01%	889
2023 Q1	$19.9K	Sell	882 -415	-32%	-$13.7K	﹤0.01%	889
2022 Q4	$46.3K	Hold	1,297	–	–	﹤0.01%	855
2022 Q3	$51K	Hold	1,297	–	–	﹤0.01%	782
2022 Q2	$62K	Hold	1,297	–	–	﹤0.01%	870
2022 Q1	$120K	Buy	1,297 +467	+56%	+$63.4K	﹤0.01%	884
2021 Q4	$184K	Hold	830	–	–	﹤0.01%	886
2021 Q3	$287K	Buy	830 +257	+45%	+$87.1K	﹤0.01%	704
2021 Q2	$215K	Hold	573	–	–	﹤0.01%	821
2021 Q1	$178K	Buy	573 +158	+38%	+$55.3K	﹤0.01%	814
2020 Q4	$104K	Hold	415	–	–	﹤0.01%	775
2020 Q3	$77K	Hold	415	–	–	﹤0.01%	726
2020 Q2	$104K	Buy	+415	New	+$90.9K	﹤0.01%	741

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Veritable's DTIL Position: Q3 2023 in Review

Veritable sold out of Precision BioSciences (DTIL) in Q3 2023, closing a stake of 882 shares — an estimated $13.9K sold.

Veritable first reported a position in DTIL in Q2 2020 and held it in 13 quarters. The position peaked at $287K in Q3 2021. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

Veritable reported no remaining Precision BioSciences position as of Q3 2023 after selling out during the quarter.
Veritable sold 882 Precision BioSciences shares in Q3 2023, an estimated $13.9K.
Veritable first reported a position in Precision BioSciences in Q2 2020 and held it in 13 quarters.
Veritable's Precision BioSciences position peaked at $287K in Q3 2021.
76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.